Search Legislation

The Medicines (Advisory Bodies) (No. 2) Regulations 2005

What Version

 Help about what version
  • Latest available (Revised)
  • Original (As made)

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Regulation 5

SCHEDULE 4CONSEQUENTIAL AMENDMENTS TO OTHER ENACTMENTS

This schedule has no associated Explanatory Memorandum

1.  In the Medicines (Extension to Antimicrobial Substances) Order 1973(1), in regulation 2 (application of specified provisions of the Act to certain classes of substances), in paragraph (1), for “sections 20 to 22” substitute “sections 20 to 22A”.

2.  In the Medicines (Labelling) Regulations 1976(2), in regulation 17 (general provisions), in paragraph (6), for “Medicines Commission” substitute “Commission on Human Medicines”.

3.  In the Medicines (Administration of Radioactive Substances) Regulations 1978(3)—

(a)in regulation 3 (advisory committee), in paragraph (4), for “paragraph 1(a) of Schedule 1” substitute “paragraph 6(a) of Schedule 1A”(4);

(b)in regulation 7 (hearings and written representations), for paragraph (3) substitute—

(3) The provisions of subsections (2) to (9) and (10)(b) of section 22A of the Act shall have effect in relation to a person appointed under paragraph 1 of this regulation and to proceedings before him and his report—

(a)subject to sub-paragraphs (b) to (d), as they have effect for the purposes of that section;

(b)as though in subsections (4), (5), (6), (7), (9) and (10)(b), for “licensing authority”, in each place those words appear, were substituted “Health Ministers”;

(c)as in though in subsection (5)(b)—

(i)for “licence” there were substituted “certificate”, and

(ii)for “and notify the applicant accordingly” there were substituted “or to suspend, revoke or vary the certificate, as the case may be”; and

(d)as though in subsection (9)(b)—

(i)for “licence” there were substituted “certificate”, and

(ii)for “confirm or alter their decision” there were substituted “suspend, revoke or vary the certificate”..

4.  In the Medicines (Exemption from Licences) (Importation) Order 1984(5), in article 2 (interpretation), in sub-paragraph (1)(a), in the definition of “British approved name” for “Medicines Commission” substitute “Commission”.

5.  In the Medicines (Fixing of Fees Relating to Medicinal Products for Human Use) Order 1989(6)—

(a)in Schedule 1—

(i)in paragraph 3, for “Medicines Commission” substitute “Commission on Human Medicines”;

(ii)in paragraph 4, for “the Committee on Safety of Medicines” substitute “the Advisory Board on the Registration of Homoeopathic Products and the Herbal Medicines Advisory Committee”;

(iii)after paragraph 9B, insert the following paragraphs—

9C.  Functions of the licensing authority which are functions of theirs by virtue of the Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005 and the functions of any person appointed under Schedule 2 to those Regulations.

9D.  Functions of the licensing authority which are functions of theirs by virtue of the Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994(7) and the functions of any person appointed under Schedule 5 to those Regulations.;

(b)in Schedule 2, in paragraph 1, for “Medicines Commission” substitute “Commission on Human Medicines”.

6.  In the Medicines Act 1968 (Application to Radiopharmaceutical-associated Products) Regulations 1992(8), in the Schedule—

(a)for “sections 20 to 22” substitute “sections 20 to 22A”; and

(b)for the entry relating to Schedule 2 of the Act, substitute the following entry—

  • as though in paragraph 6 sub-paragraph (a) were omitted;

  • as though in paragraph 9 the words “if the licence is a product licence,” were omitted;

  • as though in sub-paragraph (b) of paragraph 10 the words “in the case of a product licence,” were omitted..

7.—(1) The Unlicensed Medicinal Products for Human Use (Transmissible Spongiform Encephalopathies) (Safety) Regulations 2003(9) shall be amended as follows.

(2) In regulation 1 (citation, commencement and interpretation), in paragraph (2)—

(a)after the definition of “the 1994 Regulations”, insert the following definition—

“the appropriate committee” means—

(a)

in a case where—

(i)

a committee has been established under section 4 of the Act for purposes which consist of or include any of those specified in subsection (3) of that section, and

(ii)

the appropriate Minister considers it to be the appropriate committee in the circumstances,

that committee; and

(b)

in any other case, the Commission on Human Medicines established by section 2A of the 1968 Act;; and

(b)omit the definition of “CSM”.

(3) In regulation 3 (procedure for determinations of compliance with the TSE Guideline)—

(a)in sub-paragraph (3)(b)(ii), for “CSM” (in both places where it appears), substitute “appropriate committee”;

(b)in paragraph (4), for “CSM”, substitute “appropriate committee”;

(c)in paragraph (5), for “CSM” (in both places where it appears), substitute “appropriate committee”;

(d)in paragraph (7), for “CSM”, substitute “appropriate committee”.

(e)in paragraph (8), for “CSM” (in each place where it appears), substitute “appropriate committee”.

(1)

S.I. 1973/367.

(2)

S.I. 1976/1726, amended by S.I. 1996/2194; there are other amending instruments but none is relevant.

(3)

S.I. 1978/1006, amended by S.I. 1995/2147.

(4)

Schedule 1A to the Act was inserted by regulation 7 of S.I. 2005/1094, which came into force on 31st May 2005 for the purposes of making regulations under paragraph 6 of Schedule 1A.

(5)

S.I. 1984/673.

(6)

S.I. 1989/684, amended by S.I. 1995/871, 2004/1031.

(8)

S.I. 1992/605, to which there are amendments not relevant to these regulations.

(9)

S.I. 2003/1680, to which there are amendments not relevant to these regulations.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources